Synonyms: afabicin desphosphono | AFN-1252 | AFN-12520000 | DEBIO-1452 | DEBIO1452
Compound class:
Synthetic organic
Comment: DEBIO 1452 (previously AFN-1252) is the active metabolite of afabicin (DEBIO 1450) [3]. It is an inhibitor of bacterial Fabl, the NADH-dependent enoyl reductase from the type II bacterial fatty acid biosynthesis pathway (FAS-II) [1-2]. It specifically targets staphylococci without significant activity against other Gram +ve or Gram -ve species [2].
|
|
References |
1. Flamm RK, Rhomberg PR, Kaplan N, Jones RN, Farrell DJ. (2015)
Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains. Antimicrob Agents Chemother, 59 (5): 2583-7. [PMID:25691627] |
2. Peyrusson F, Van Wessem A, Dieppois G, Van Bambeke F, Tulkens PM. (2020)
Cellular pharmacokinetics and intracellular activity of the bacterial fatty acid synthesis inhibitor, afabicin desphosphono against different resistance phenotypes of Staphylococcus aureus in models of cultured phagocytic cells. Int J Antimicrob Agents, 55 (2): 105848. [PMID:31770623] |
3. Ross JE, Flamm RK, Jones RN. (2015)
Initial broth microdilution quality control guidelines for Debio 1452, a FabI inhibitor antimicrobial agent. Antimicrob Agents Chemother, 59 (11): 7151-2. [PMID:26324261] |